Riskpilot← Back to searchSign inGet full accessVendelakliniken AB
ABActiveOrg 5568750003Kyrkogatan 14Medical specialists activities · NACE 8622Est. 20111 employees
Revenue 2025
SEK 2,6M
+3% vs 2024
EBITDA margin
20.8%
+15% vs 2024
Equity ratio
93.0%
Financial strength
Net profit 2025
SEK 546K
+4% vs 2024
| Revenue | SEK 2,6M | +3% |
| EBITDA | SEK 551K | +15% |
| Net profit | SEK 546K | +4% |
| Total assets | SEK 5M | +5% |
| Equity | SEK 4,6M | +10% |
| Employees | 1 | — |
Legal name
Vendelakliniken AB
Org number
5568750003
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 december 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva estetiska skönhetsbehandlingar som utföres av läkare och sjuksköterska och därmed liknande verksamhet.
Address
Kyrkogatan 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 348 | 2 532 | 2 440 | 2 567 | 2 649 |
| Staff expenses | — | −995 | −1 019 | −969 | −993 |
| EBITDA | 291 | 352 | 359 | 479 | 551 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 291 | 352 | 359 | 479 | 551 |
| Net financials | 402 | 380 | 0 | −0 | 0 |
| Profit before tax | 1 154 | 891 | 517 | 671 | 692 |
| Tax | −97 | −125 | −111 | −144 | −145 |
| Net profit | 1 057 | 765 | 406 | 528 | 546 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 584 | 4 224 | 4 420 | 4 735 | 4 973 |
| Equity | 2 509 | 3 274 | 3 680 | 4 208 | 4 624 |
| Long-term debt | 0 | 1 | 0 | — | — |
| Short-term debt | 281 | 313 | 263 | 242 | 205 |
| Total debt | 281 | 314 | 263 | 242 | 205 |
EBITDA margin
20.8%
This company
15.8%
Market median
+32% vs market
20212025
Equity ratio
93.0%
This company
38.2%
Market median
+143% vs market
20212025
Return on equity
11.8%
This company
18.4%
Market median
+36% vs market
20212025
Net profit margin
20.6%
This company
8.1%
Market median
+154% vs market
20212025
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20212025
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vendelakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per David Rosengren | Deputy Board Member | 0 companies |
| Petra Victoria Elisabeth Rosengren | Board of Directors | 0 companies |